Xiaojuan Xu Selected Research

poly(dA)

2/2021	Fabrication of tumor-targeting composites based on the triple helical β-glucan through conjugation of aptamer.
1/2019	Nanoplatform Constructed from a β-Glucan and Polydeoxyadenylic Acid for Cancer Chemotherapy and Imaging.
1/2019	Orally Delivered Antisense Oligodeoxyribonucleotides of TNF-α via Polysaccharide-Based Nanocomposites Targeting Intestinal Inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaojuan Xu Research Topics

Disease

25	Neoplasms (Cancer) 12/2021 - 06/2005
7	Inflammation (Inflammations) 01/2022 - 12/2016
7	Polymorphic catecholergic ventricular tachycardia 01/2019 - 02/2009
6	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 07/2016
5	Infections 01/2021 - 11/2007
4	Ventricular Tachycardia 01/2018 - 05/2009
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 02/2020
3	Neoplasm Metastasis (Metastasis) 05/2021 - 01/2017
3	Colitis 09/2020 - 08/2017
3	Obesity 03/2018 - 12/2016
3	Heart Failure 01/2017 - 05/2009
2	Thoracic Aortic Aneurysm 01/2022 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 03/2021
2	Diarrhea 12/2021 - 05/2017
2	Osteoporosis 06/2021 - 01/2015
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2019
2	Body Weight (Weight, Body) 03/2018 - 03/2005
2	Autistic Disorder (Autism) 01/2017 - 09/2015
2	Cardiac Arrhythmias (Arrythmia) 01/2017 - 04/2010
2	Necrosis 01/2016 - 09/2015
2	Malignant Hyperthermia 11/2010 - 05/2009
2	Influenza in Birds (Avian Flu) 06/2006 - 04/2005
2	Sarcoma 180 01/2006 - 06/2005
1	Rheumatoid Arthritis 05/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Bicuspid Aortic Valve Disease 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Aortic Dissection 01/2022
1	Respiratory Hypersensitivity 01/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021
1	Hepatitis 12/2021
1	Fever (Fevers) 12/2021
1	Carcinoma (Carcinomatosis) 10/2021
1	Atherosclerosis 03/2021
1	Diabetes Complications 03/2021

Drug/Important Bio-Agent (IBA)

17	GlucansIBA 05/2022 - 01/2006
11	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 02/2009
8	Polysaccharides (Glycans)IBA 10/2021 - 05/2014
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2004
6	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2021 - 04/2010
6	Pharmaceutical PreparationsIBA 01/2021 - 05/2009
3	NaphthalimidesIBA 10/2021 - 02/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2017
3	poly(dA)IBA 02/2021 - 01/2019
3	LentinanIBA 02/2021 - 06/2005
3	Dextrans (Dextran)FDA Link 09/2020 - 08/2017
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 09/2020 - 08/2017
3	Amino Acids FDA Link 11/2017 - 11/2010
3	Dantrolene (Dantrium)FDA LinkGeneric 08/2011 - 05/2009
2	Methotrexate (Mexate)FDA LinkGeneric 05/2022 - 01/2020
2	N-acetylVal-Nle(7,8)- allatotropin (5-13) (ATAA)IBA 01/2022 - 01/2022
2	PolyaminesIBA 10/2021 - 01/2017
2	2-benzyl-3-formylpropanoic acid (BFP)IBA 10/2021 - 07/2020
2	Indicators and Reagents (Reagents)IBA 03/2021 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2017
2	SolutionsIBA 11/2020 - 07/2016
2	polyglucosanIBA 07/2020 - 07/2016
2	AntigensIBA 04/2020 - 01/2019
2	CytokinesIBA 11/2019 - 01/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2016
2	AcidsIBA 01/2019 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 03/2018 - 12/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2016
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2018 - 11/2010
2	Caspase 3 (Caspase-3)IBA 10/2017 - 01/2016
2	CaspasesIBA 10/2017 - 01/2016
2	AntibodiesIBA 06/2006 - 04/2005
2	LatexIBA 06/2006 - 04/2005
1	Immunoglobulin E (IgE)IBA 01/2022
1	OrganophosphatesIBA 01/2022
1	Flame Retardants (Fire Retardants)IBA 01/2022
1	OvalbuminIBA 01/2022
1	cytolethal distending toxinIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	daidzinIBA 12/2021
1	matrigelIBA 12/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021
1	flavoneIBA 10/2021
1	Biological ProductsIBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	CreatinineIBA 06/2021
1	C-PeptideIBA 06/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2021
1	lycorineIBA 05/2021
1	RNA (Ribonucleic Acid)IBA 05/2021
1	Superoxide DismutaseIBA 03/2021
1	NAD (NADH)IBA 03/2021
1	Nucleic AcidsIBA 02/2021
1	isothiocyanic acidIBA 02/2021
1	Fluorescein-5-isothiocyanate (FITC)IBA 02/2021
1	Neuraminidase (Sialidase)IBA 01/2021
1	ProdrugsIBA 01/2021
1	PlatinumIBA 01/2021

Therapy/Procedure

13	Therapeutics 05/2022 - 11/2007
2	Immunomodulation 11/2019 - 06/2019
2	Oral Administration 03/2018 - 08/2017
1	Neoadjuvant Therapy 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2021